Who Just RaisedHealth Care · Woodcliff Lake, NJNew
Ensho Therapeutics, Inc.
Ensho Therapeutics, Inc. is a biotechnology company based in Woodcliff Lake, New Jersey. In a Form D filed with the SEC on October 15, 2026, it reported raising $7,281,948 from 7 investors as part of an offering of up to $15,604,179. The first sale in the offering took place on October 2, 2026.
- 5th Form D since 2024. Earlier new notices: Feb 9, 2026 · Sep 12, 2025 · Nov 12, 2024 · Aug 6, 2024. All filings on EDGAR
- Still raising. $8.3M of the $15.6M offering was still unsold at filing.
$35.2M raised since 2020
5 Form D offerings, as reported to the SEC, the first in Aug 6, 2024. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Oct 15, 2026 | $7.3M | $15.6M | 7 |
| Feb 9, 2026 | — | $20M | 9 |
| Sep 12, 2025 | $22.5M | $22.5M | 2 |
| Nov 12, 2024 | $5M | $12.5M | 1 |
| Aug 6, 2024 | $400K | $2M | 2 |
Lead score
44 out of 100
filed this week still raising budget to spend young company
Outreach kit
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round, Ensho Therapeutics
Hi there, Congrats on the new round at Ensho Therapeutics. I saw the $7.3M raise in your SEC filing on Oct 15, and that the round is still open. Teams scaling up after a new round usually start looking at [what you do] soon after, and that's what we help with: [one line on the result you deliver]. Would a 15-minute call next week be useful? Happy to share what similar companies did in their first months after raising. [Your name]
LinkedIn note
Congrats on the new round at Ensho Therapeutics. Saw the $7.3M raise in your Form D. I work with [who you help] on [what you do] right after a round. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I'm calling because Ensho Therapeutics just filed a $7.3M raise with the SEC. Teams scaling up after a new round often need [what you do], so I wanted to ask who looks after that at Ensho Therapeutics.
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company
Saved to your dashboard pipeline, with a badge in Explore.
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $7,281,948
- Offering size
- $15,604,179
- Investors so far
- 7
- Minimum investment
- $1
- First sale
- October 2, 2026
- Securities offered
- Equity, Securities issuable on exercise or conversion
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Woodcliff Lake, New Jersey
- Incorporated
- Delaware, 2024
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $7,281,948 | $15,604,179 | 7 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Similar raises
Surgical Center of South Jersey LP
Mt. Laurel, NJ · filed Oct 811th Form D since 2010Still raising
Lisata Therapeutics, Inc.
Basking Ridge, NJ · filed Oct 2
Clinical-stage biopharmaceutical company developing therapies for solid tumors, including cancer drugs designed to improve delivery into tumor tissue.
8th Form D since 2014
Morris County Surgical Center, LLC
Parsippany, NJ · filed Sep 283rd Form D since 2021Still raising
Acuitive Technologies, Inc.
Allendale, NJ · filed Sep 244th Form D since 2021Still raising